- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07851116
Tissue Sensor to Reduce the Need for Controlled Apnea During Retrograde Intrarenal Surgery (Tissue Sensor)
Retrograde intrarenal surgery is an established minimally invasive treatment for renal stones. During laser lithotripsy, respiratory motion causes the kidney, renal collecting system, and stone to move relative to the distal tip of the laser fiber. This can impair precise fiber positioning, reduce operative-field stability, and increase the risk of unintended laser exposure of the urothelium of the renal collecting system.
To reduce respiratory motion of the kidney, the surgeon may ask the anesthesiologist to temporarily pause mechanical ventilation. Controlled apnea can briefly stabilize the operative field; however, it requires interruption of ventilation and may cause oxygen desaturation, carbon dioxide accumulation, hemodynamic changes, and increased anesthetic burden.
Tissue Sensor is a technology that automatically terminates laser emission when contact between the distal tip of the laser fiber and tissue is detected. Tissue Sensor is expected to reduce the risk of unintended laser exposure of the renal collecting-system mucosa during respiratory motion of the kidney.
Greater surgeon confidence in the safety of laser activation may reduce the need to stabilize the kidney with controlled apnea. At the same time, brief automatic interruptions of laser emission may increase lithotripsy time and total operative time.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Nikita Astakhov
- Phone Number: +8 (968) 490-46-72
- Email: astakhov.nikita@inbox.ru
Study Contact Backup
- Name: Vigen Malkhasyan, Doctor of Medical Sciences
- Phone Number: +79096441688
- Email: botkinhospital@zdrav.mos.ru
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18 years or older.
- A single renal stone.
- An indication for elective RIRS.
- Feasibility of performing the intervention with a flexible ureteroscope.
- Recommended stone diameter on CT: 7-15 mm.
- Stone located in a calyx, a group of calyces, or the renal pelvis.
- Feasibility of TFL use.
- General anesthesia with controlled mechanical ventilation.
- No active urinary tract infection.
- Ability to undergo low-dose non-contrast CT at 1 month.
- Signed written informed consent.
Exclusion Criteria:
- Multiple stones in the study kidney.
- Complete or partial staghorn stone.
- Ipsilateral ureteral stone.
- Renal or upper urinary tract anomaly that substantially alters the anatomy.
- Horseshoe, pelvic, or ectopic kidney.
- Stone within a calyceal diverticulum.
- Ureteral stricture.
- Previous reconstructive surgery involving the study kidney or ureter.
- Active infection, obstructive pyelonephritis, or urosepsis.
- Nephrostomy drainage.
- Pregnancy.
- Severe respiratory failure or a contraindication to apnea.
- Severe cardiovascular instability.
- Inability to undergo general anesthesia.
- Combined, bilateral, or percutaneous intervention.
- Suspected upper urinary tract tumor.
- Inability to comply with the study protocol.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: patients with a single renal stone who are scheduled for elective retrograde intrarenal surger
RIRS will be performed using a thulium fiber laser with Tissue Sensor activated. All automatic system trigger events will be recorded and, whenever possible, synchronized with the procedure video recording. |
RIRS will be performed using the same TFL system with Tissue Sensor deactivated. Visually confirmed contacts between the activated laser fiber and the mucosa will be recorded from the procedure video. RIRS will be performed using a thulium fiber laser with Tissue Sensor activated. All automatic system trigger events will be recorded and, whenever possible, synchronized with the procedure video recording.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Proportion of patients requiring at least one episode of controlled intraoperative apnea during laser lithotripsy.
Time Frame: intraoperative
|
intraoperative
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
• number of apnea episodes;
Time Frame: intraoperative
|
intraoperative
|
|
total apnea duration;
Time Frame: intraoperative
|
intraoperative
|
|
mean number of apnea episodes per patient;
Time Frame: intraoperative
|
intraoperative
|
|
maximum duration of a single apnea episode;
Time Frame: intraoperative
|
intraoperative
|
|
minimum SpO2;
Time Frame: intraoperative
|
intraoperative
|
|
incidence of desaturation;
Time Frame: intraoperative
|
intraoperative
|
|
visible laser-induced mucosal
Time Frame: intraoperative
|
intraoperative
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- MoscowBotkinHospital3
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.